Wrong...I am not a contrarian per se. The difference in opinions we share are a direct result of our divergence on the root cause of Corx's ills. Your unrealistic timeline (only the most naïve of us would anticipate such a near term target of 2011) on an ADHD deal is a perfect example of what I am attempting to convey.
As far as neuropharm disagreeing with my opinion on royalties and RD: They are not the investors at large I am referring to/banking on, that would speculate on a huge potential windfall-- based on this very significant RD discovery with Corx's compounds and science.
Neuro--If the highlight of your post(s) is to put me down, why bother responding. I'm reasonable enough to follow logical arguments, not blinded enough to blame everything on mngmt, and aware enough to detect spin when I see it repeatedly, so please channel your defensiveness to something less indulgent.